On a Saturday in October, a small audience gathered in New York City to hear recent highlights from Parkinson’s research efforts toward new treatments and cures. In this podcast, we open that conversation for others not able to join our Research Roundtable. Our MJFF Chief Scientific Officers recap the discussion and react to clips from the Roundtable’s expert panel of scientists, program leaders and a person with Parkinson’s. You’ll hear updates around treatments to stop disease; efforts to ban Parkinson’s-linked toxicants from the environment; and the relaunch of our landmark study that could change everything about how patients, families, doctors and scientists think about brain disease.
Maggie Kuhl, MJFF Director of Research Communications, hosts this podcast episode. She speaks with Co-Chief Scientific Officers Brian Fiske, PhD, and Mark Frasier, PhD.
Soundbites are shared from Research Roundtable panelists:
- Warren Hirst, PhD: Senior Director of the Neurodegeneration Research Unit, Biogen
- Katie Kopil, PhD: Vice President, Research Partnerships, MJFF
- Ken Marek, MD: President and Senior Scientist, Institute for Neurodegenerative Disorders
- Ekemini Riley, PhD: Managing Director, Aligning Science Across Parkinson’s (ASAP) Initiative
- Bryan Roberts: MJFF Patient Council Member
View a transcript of this podcast.
For more on the latest from Parkinson’s research and how you can get involved, visit our website at www.michaeljfox.org.
